Unsafe
Non-Compliant
Patient Risk:
High
Summary
Severe label mismatch: the provided FDA label content appears to be for AndroGel 1% (topical) while the extracted claims evaluate testosterone enanthate (injectable). As a result, most dosing/route, safety, and adverse reaction-related statements are not verifiable against the supplied label sections.
Category Scores
Accurate Statements
Testosterone enanthate is prescribed to treat testosterone deficiency in men.
Supported only at a general concept level by the provided label’s Section 1 (testosterone replacement therapy for adult males with deficiency/absence of endogenous testosterone). Provided label is for AndroGel 1%, not testosterone enanthate injection.
Testosterone enanthate is used medically to treat hypogonadism.
Supported only at a general concept level by the provided label’s Section 1 (primary hypogonadism and hypogonadotropic hypogonadism as indications). Provided label is for AndroGel 1%, not testosterone enanthate injection.
Unsupported Statements
Testosterone enanthate is available as a generic medication.
Not present in the supplied label sections.
Generic testosterone enanthate is manufactured by multiple companies.
Not present in the supplied label sections.
Generic testosterone enanthate is typically less expensive than brand-name counterparts.
Not present in the supplied label sections.
Testosterone enanthate is an injectable form of testosterone.
No support for route/form for testosterone enanthate in the provided label (supplied label appears to be for topical AndroGel 1%).
Testosterone enanthate is administered intramuscularly.
No support for route for testosterone enanthate in the provided label.
Testosterone enanthate is usually administered at regular intervals.
No dosing frequency information for testosterone enanthate injection in the supplied label.
Testosterone enanthate helps to restore testosterone levels to normal.
Not supported by the supplied label sections.
Testosterone enanthate addresses symptoms such as low libido.
Not supported by the supplied label sections.
Testosterone enanthate addresses symptoms such as fatigue.
Not supported by the supplied label sections.
Testosterone enanthate addresses symptoms such as mood changes.
Not supported by the supplied label sections.
Information regarding specific patent expiry dates for testosterone enanthate can vary.
Not present in the supplied label sections.
Testosterone enanthate can cause side effects including acne.
No adverse reactions for testosterone enanthate in the supplied label sections (and provided label appears to be for AndroGel 1%).
Testosterone enanthate can cause side effects including increased red blood cell count.
Not supported by the supplied label sections.
Testosterone enanthate can cause side effects including fluid retention.
Not supported by the supplied label sections.
Testosterone enanthate can cause side effects including mood swings.
Not supported by the supplied label sections.
Testosterone enanthate can cause side effects including changes in sex drive.
Not supported by the supplied label sections.
More serious side effects can occur with testosterone enanthate.
No support in the supplied label sections.
Testosterone enanthate is one of multiple testosterone replacement therapies.
Not present in the supplied label sections.
Other injectable testosterone esters (like testosterone cypionate) exist as testosterone replacement therapies.
Not present in the supplied label sections.
Transdermal patches exist as testosterone replacement therapies.
Not present in the supplied label sections.
Gels exist as testosterone replacement therapies.
Not present in the supplied label sections.
Implants exist as testosterone replacement therapies.
Not present in the supplied label sections.
Other testosterone replacement therapies have different administration schedules, absorption rates, and potential side effect profiles.
Not present in the supplied label sections.
Several pharmaceutical companies produce generic versions of testosterone enanthate.
Not present in the supplied label sections.
Pfizer produces generic versions of testosterone enanthate.
Not present in the supplied label sections.
Pfizer originally marketed Depo-Testosterone, a brand name for testosterone enanthate.
Not present in the supplied label sections.
Hikma Pharmaceuticals produces generic versions of testosterone enanthate.
Not present in the supplied label sections.
Testosterone enanthate and testosterone cypionate are both injectable esters of testosterone.
No support in the supplied label sections.
Testosterone enanthate and testosterone cypionate are commonly used for hormone replacement therapy.
No support in the supplied label sections.
The primary difference between testosterone enanthate and testosterone cypionate is ester chain length.
No support in the supplied label sections.
Ester chain length affects absorption and duration of action in the body.
No support in the supplied label sections.
Testosterone enanthate has a slightly longer ester chain.
No support in the supplied label sections.
Testosterone enanthate has a slightly longer half-life.
No support in the supplied label sections.
Testosterone enanthate may require injections every 2 to 4 weeks.
No dosing interval for testosterone enanthate injection is provided in the supplied label sections.
Testosterone cypionate is often injected every 1 to 2 weeks.
No support in the supplied label sections.
Testosterone enanthate is sometimes misused by athletes and bodybuilders to enhance muscle growth and performance.
Not present in the supplied label sections.
Non-medically indicated use of testosterone enanthate carries significant health risks.
Not present in the supplied label sections.
The U.S. Food and Drug Administration (FDA) has issued warnings about the dangers of unapproved testosterone use.
Not present in the supplied label sections.
Contradictions
Important Omissions
Correct route/formulation-specific prescribing details for testosterone enanthate injectable (e.g., dosing, administration instructions, product-specific contraindications/warnings/adverse reactions).
Importance:
High
Boxed warning / prominent warnings and precaution content for the specific testosterone enanthate injectable product is not verified against the supplied label sections.
Importance:
High
Drug interactions section verification for testosterone enanthate injectable is not possible from the supplied label sections.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
High
The extracted claims include route/dosing and multiple safety/side-effect statements that are not verifiable against the supplied label content, which appears to be for a different product (AndroGel 1% topical). This label mismatch undermines accuracy of safety-critical information.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Non-Compliant
Primary Issue
Provided label content appears to be for AndroGel 1% (topical) rather than testosterone enanthate injectable; most extracted claims are therefore not supported and cannot be verified against the supplied FDA-approved prescribing information.
Suggested Improvement
Re-run the audit using the FDA-approved label specifically for testosterone enanthate injectable (matching product name and dosage form), then map each claim to the correct sections (Indications/Contraindications/Warn. & Prec./Drug Interactions/Adverse Reactions/Dosage & Administration/Use in Specific Populations). Remove non-label market/manufacturer/patent assertions unless directly present in the label.